Factors associated with non-adherence to antiretroviral treatment among people living with HIV monitored in health centers in the Ouabri region, Burkina Faso
DOI:
https://doi.org/10.4314/Keywords:
HIV, adherence, antiretroviral, Burkina FasoAbstract
The WHO's “test and treat” strategy has helped increase the number of people living with HIV on antiretroviral drugs. However, the goal of neutralizing plasma viral load is far from being achieved. Adherence, one of the keys to this neutralization, remains a challenge. The objective of our study was to identify the factors associated with non-adherence to antiretroviral treatment in the Oubri region, one of the seventeen regions of Burkina Faso. We conducted an analytical study from June to December 2024. People living with HIV aged 18 years or older were interviewed as they came in for their follow-up visits. Adherence was calculated based on their reports of medication use. People who had missed at least one day of medication were considered non-adherent. A logistic regression at the 5% threshold allowed us to identify the associated factors. The average age of the participants was 45.89± 12.04. There were 232 women (70.73%) and 96 men (29.27%). The proportion of non-adherent individuals was 20%. The factors independently associated with non-compliance were difficulties in traveling to the health center due to distance (OR 4.23, 95% CI [2.24-8]) and perception of the severity of HIV-related illness (OR 1.97, 95% CI [1.1-3.56]). It is necessary to bring follow-up centers closer to the population, and community adherence support strategies are recommended.
Downloads
References
-Level-of-Adherence-to-Antiretroviral-Therapy.pdf. (s. d.). Consulté à l’adresse https://www.annexpublishers.com/articles/JAVR/2103-Level-of-Adherence-to-Antiretroviral-Therapy.pdf
Ahmed, I., Tefera, F., Bekele, A., Ayalew, J., Tessema, F., Abera, G., … Shah, M. (2025). Suboptimal adherence to antiretroviral treatment and its predictors among people living with HIV in the era of test and treat. Scientific Reports, 15(1), 12666. https://doi.org/10.1038/s41598-025-96631-1
Améliorer L’Accès Aux Traitements Antirétroviraux Dans Les Pays À Ressources Limitées | PDF | VIH | SIDA. (s. d.). Consulté 4 décembre 2025, à l’adresse https://fr.scribd.com/document/906515448/9242591556?utm_source=chatgpt.com
Anakwa, N. O., Teye‐Kwadjo, E., & Kretchy, I. A. (2021). Illness perceptions, social support and antiretroviral medication adherence in people living with HIV in the greater Accra region, Ghana. Nursing Open, 8(5), 2595‑2604. https://doi.org/10.1002/nop2.797
Annuaire_2024_ms__signe___18062025. (s. d.).
Bezabhe, W. M., Chalmers, L., Bereznicki, L. R., & Peterson, G. M. (2016). Adherence to Antiretroviral Therapy and Virologic Failure. Medicine, 95(15), e3361. https://doi.org/10.1097/MD.0000000000003361
Bondarchuk, C. P., Mlandu, N., Adams, T., & Vries, E. de. (2022). Predictors of low antiretroviral adherence at an urban South African clinic : A mixed-methods study. Southern African Journal of HIV Medicine, 23(1), 8. https://doi.org/10.4102/sajhivmed.v23i1.1343
Brittain, K., Remien, R. H., Mellins, C. A., Phillips, T. K., Zerbe, A., Abrams, E. J., & Myer, L. (2018). Determinants of suboptimal adherence and elevated HIV viral load in pregnant women already on antiretroviral therapy when entering antenatal care in Cape Town, South Africa. AIDS Care, 30(12), 1517‑1523. https://doi.org/10.1080/09540121.2018.1503637
Buh, A., Deonandan, R., Gomes, J., Krentel, A., Oladimeji, O., & Yaya, S. (2023). Prevalence and factors associated with HIV treatment non-adherence among people living with HIV in three regions of Cameroon : A cross-sectional study. PloS One, 18(4), e0283991. https://doi.org/10.1371/journal.pone.0283991
Buregyeya, E., Naigino, R., Mukose, A., Makumbi, F., Esiru, G., Arinaitwe, J., … Wanyenze, R. K. (2017). Facilitators and barriers to uptake and adherence to lifelong antiretroviral therapy among HIV infected pregnant women in Uganda : A qualitative study. BMC Pregnancy and Childbirth, 17(1), 94. https://doi.org/10.1186/s12884-017-1276-x
Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection : Recommendations for a public health approach, 2nd ed. (s. d.). Consulté 4 décembre 2025, à l’adresse https://www.who.int/publications/i/item/9789241549684
Damulak, P. P., Ismail, S., Abdul Manaf, R., Mohd Said, S., & Agbaji, O. (2021). Interventions to Improve Adherence to Antiretroviral Therapy (ART) in Sub-Saharan Africa : An Updated Systematic Review. International Journal of Environmental Research and Public Health, 18(5), 2477. https://doi.org/10.3390/ijerph18052477
Demissie, A. A., & van Rensburg, E. J. (2024). Highly active antiretroviral therapy adherence among HIV-POSITIVE women in Southern Ethiopia. Frontiers in Pharmacology, 15, 1420979. https://doi.org/10.3389/fphar.2024.1420979
Determinants of adherence to antiretroviral therapy among HIV-positive adults in sub-Saharan Africa : A systematic review | BMJ Global Health. (s. d.). Consulté 10 décembre 2025, à l’adresse https://gh.bmj.com/content/1/4/e000125?utm_source=chatgpt.com
Fiche d’information—Dernières statistiques sur l’état de l’épidémie de sida | UNAIDS. (s. d.). Consulté 4 décembre 2025, à l’adresse https://www.unaids.org/fr/resources/documents/2025/UNAIDS_FactSheet
Macleod, D., Shanaube, K., Skalland, T., Limbada, M., Mandla, N., Bwalya, J., … Floyd, S. (2022). Viral suppression and self-reported ART adherence after 3 years of universal testing and treatment in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa : A cross-sectional analysis. The Lancet HIV, 9(11), e751‑e759. https://doi.org/10.1016/S2352-3018(22)00237-5
Magura, J., Nhari, S. R., & Nzimakwe, T. I. (2025). Barriers to ART adherence in sub-Saharan Africa : A scoping review toward achieving UNAIDS 95-95-95 targets. Frontiers in Public Health, 13, 1609743. https://doi.org/10.3389/fpubh.2025.1609743
Makhado, L., & Mongale, M. P. (2019). Factors influencing non-adherence to antiretroviral therapy in South Africa : A systematic review. HIV & AIDS Review, 18(4), 239‑246. https://doi.org/10.5114/hivar.2019.89448
Milward de Azevedo Meiners, M. M., Araújo Cruz, I., & de Toledo, M. I. (2023). Adherence to antiretroviral therapy and viral suppression : Analysis of three periods between 2011 and 2017 at an HIV-AIDS center, Brazil. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1122018
Msellati, P., Vidal, L., & Moatti, J.-P. (2001). L’accès aux traitements du VIH/sida en Côte d’Ivoire : Évaluation de l’Initiative Onusida/Ministère ivoirien de la santé publique : aspects économiques, sociaux et comportementaux. Paris: ANRS.
Muse, A. I., Osman, M. O., Ibrahim, A. M., Wedajo, G. T., Abdi, M. M., & Roble, A. K. (2023). Non-adherence to antiretroviral therapy and associated factors among adult HIV patients in Somali region public Hospitals, eastern Ethiopia. International Journal of Africa Nursing Sciences, 19, 100645. https://doi.org/10.1016/j.ijans.2023.100645
Namakula, E., Mugerwa, H., Kitutu, F. E., Kawuma, A. N., Kiguba, R. K. R., & Kalyango, J. N. (2025). Prevalence and factors associated with suboptimal adherence to dolutegravir-based regimens among people living with HIV in a specialized clinic in Kampala, Uganda. A cross-sectional study. Student’s Journal of Health Research Africa, 6(9), 10‑10. https://doi.org/10.51168/sjhrafrica.v6i9.2067
Ndoro, T., Ndlovu, N., & Nyasulu, P. (2022). Factors associated with ART adherence among HIV-positive adherence club members in Ekurhuleni Metropolitan Municipality, South Africa : A cross-sectional study. PloS One, 17(11), e0277039. https://doi.org/10.1371/journal.pone.0277039
OMS Burkina Faso_Rapport biennal 2022-2023.pdf. (s. d.).
Pefura-Yone, E. W., Soh, E., Kengne, A. P., Balkissou, A. D., & Kuaban, C. (2013). Non-adherence to antiretroviral therapy in Yaounde : Prevalence, determinants and the concordance of two screening criteria. Journal of Infection and Public Health, 6(4), 307‑315. https://doi.org/10.1016/j.jiph.2013.02.003
Principaux repères sur le VIH/sida. (s. d.). Consulté 4 décembre 2025, à l’adresse https://www.who.int/fr/news-room/fact-sheets/detail/hiv-aids
UNAIDS announces 2 million more people living with HIV on treatment in 2015, bringing new total to 17 million | UNAIDS. (s. d.). Consulté 4 décembre 2025, à l’adresse https://www.unaids.org/en/resources/presscentre/pressreleaseandstatementarchive/2016/may/20160531_Global-AIDS-Update-2016
Wilkinson, L. S. (2013). ART adherence clubs : A long-term retention strategy for clinically stable patients receiving antiretroviral therapy. Southern African Journal of HIV Medicine, 14(2), 48‑50. Consulté à l’adresse https://sajhivmed.org.za/index.php/hivmed/article/view/77
Yameogo, W. N. Z., Yabre, D. H. L., Bakiono, F., Belem, A. R., Compaore, T., Kangouye, D., … Drabo, K. M. (2025). Connaissances et perceptions des personnes vivant avec le VIH sur les dispositifs d’aide à l’observance dans les centres de traitement de la région du Plateau-Central du Burkina Faso, novembre 2024. MTSI, 5(2). https://doi.org/10.48327/mtsi.v5i2.2025.643
Zoungrana-Yameogo, W. N., Fassinou, L. C., Ngwasiri, C., Samadoulougou, S., Traoré, I. T., Hien, H., … Kirakoya-Samadoulougou, F. (2022). Adherence to HIV Antiretroviral Therapy Among Pregnant and Breastfeeding Women, Non-Pregnant Women, and Men in Burkina Faso : Nationwide Analysis 2019-2020. Patient Preference and Adherence, 16, 1037‑1047. https://doi.org/10.2147/PPA.S354242
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Wedminere Noelie Zoungrana Yameogo, Smaila Ouedraogo, Fidèle BATIONO, Toussaint COMPAORE, Koine Maxime DRABO
This work is licensed under a Creative Commons Attribution 4.0 International License.
https://creativecommons.org/licenses/by/4.0/
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license term
How to Cite
